Combination Chemotherapy Plus Oblimersen in Treating Patients With Advanced Solid Tumors

Summary

Phase I trial to study the effectiveness of combining carboplatin and paclitaxel with oblimersen in treating patients who have advanced solid tumors. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Oblimersen may increase the effectiveness of carboplatin and paclitaxel by making tumor cells more sensitive to the drugs.

Timeline

Start

2002-10

Primary completion

2008-05

Completion

—

Drugs

Indications